Amphastar Pharmaceuticals, Inc. Repayments of Long-Term Debt
Amphastar Pharmaceuticals, Inc. (AMPH) reported Repayments of Long-Term Debt of $76.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2026-08-06
- Amphastar Pharmaceuticals, Inc. repayments of long-term debt for the quarter ending 2026-06-30 was $47.00K, a 27.03% increase year-over-year.
- Amphastar Pharmaceuticals, Inc. repayments of long-term debt for the quarter ending 2026-03-31 was $29.00K, a 23.68% decline year-over-year.
- Amphastar Pharmaceuticals, Inc. repayments of long-term debt for the quarter ending 2025-12-31 was $104.00K, a 9.57% decline year-over-year.
- Amphastar Pharmaceuticals, Inc. repayments of long-term debt for the quarter ending 2025-09-30 was $44.00K, a 7.32% increase year-over-year.
- Amphastar Pharmaceuticals, Inc. repayments of long-term debt for fiscal 2025 was $223.00K, a 97.30% decline from fiscal 2024.
- Amphastar Pharmaceuticals, Inc. repayments of long-term debt for fiscal 2024 was $8.26M, a 97.41% decline from fiscal 2023.
- Amphastar Pharmaceuticals, Inc. repayments of long-term debt for fiscal 2023 was $318.66M, a 17792.08% increase from fiscal 2022.
- Amphastar Pharmaceuticals, Inc. repayments of long-term debt for fiscal 2022 was $1.78M, a 95.15% decline from fiscal 2021.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|
| 2026-06-30 | $47.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $76.00K 10-Q · filed 2026-08-06 | $180.00K derived: sum of 3 quarters · filed 2026-08-06 | $224.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $29.00K 10-Q · filed 2026-05-07 | $133.00K derived: sum of 2 quarters · filed 2026-05-07 | $177.00K derived: sum of 3 quarters · filed 2026-05-07 | $214.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $104.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $148.00K derived: sum of 2 quarters · filed 2026-02-26 | $185.00K derived: sum of 3 quarters · filed 2026-08-06 | $223.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $44.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $81.00K derived: sum of 2 quarters · filed 2026-08-06 | $119.00K 10-Q · filed 2025-11-06 | $234.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $37.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $75.00K 10-Q · filed 2026-08-06 | $190.00K derived: sum of 3 quarters · filed 2026-08-06 | $231.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $38.00K 10-Q · filed 2026-05-07 | $153.00K derived: sum of 2 quarters · filed 2026-05-07 | $194.00K derived: sum of 3 quarters · filed 2026-05-07 | $8.20M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $115.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $156.00K derived: sum of 2 quarters · filed 2026-02-26 | $8.16M derived: sum of 3 quarters · filed 2026-02-26 | $8.26M 10-K · filed 2026-02-26 |
| 2024-09-30 | $41.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $8.05M derived: sum of 2 quarters · filed 2025-11-06 | $8.15M 10-Q · filed 2025-11-06 | $58.30M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $8.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $8.11M 10-Q · filed 2025-08-07 | $58.26M derived: sum of 3 quarters · filed 2026-02-26 | $258.33M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $98.00K 10-Q · filed 2025-05-08 | $50.25M derived: sum of 2 quarters · filed 2026-02-26 | $250.32M derived: sum of 3 quarters · filed 2026-02-26 | $317.79M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $50.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $250.23M derived: sum of 2 quarters · filed 2026-02-26 | $317.69M derived: sum of 3 quarters · filed 2026-02-26 | $318.66M 10-K · filed 2026-02-26 |
| 2023-09-30 | $200.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $267.54M derived: sum of 2 quarters · filed 2024-11-07 | $268.51M 10-Q · filed 2024-11-07 | $268.63M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $67.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $68.43M 10-Q · filed 2024-08-09 | $68.56M derived: sum of 3 quarters · filed 2025-03-03 | $69.08M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $968.00K 10-Q · filed 2024-05-10 | $1.10M derived: sum of 2 quarters · filed 2025-03-03 | $1.62M derived: sum of 3 quarters · filed 2025-03-03 | $2.21M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | $128.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $650.00K derived: sum of 2 quarters · filed 2025-03-03 | $1.24M derived: sum of 3 quarters · filed 2025-03-03 | $1.78M 10-K · filed 2025-03-03 |
| 2022-09-30 | $522.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $1.11M derived: sum of 2 quarters · filed 2023-11-08 | $1.65M 10-Q · filed 2023-11-08 | $2.27M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $593.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $1.13M 10-Q · filed 2023-08-09 | $1.74M derived: sum of 3 quarters · filed 2024-02-29 | $30.60M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $538.00K 10-Q · filed 2023-05-09 | $1.15M derived: sum of 2 quarters · filed 2024-02-29 | $30.01M derived: sum of 3 quarters · filed 2024-02-29 | $35.28M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $613.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $29.47M derived: sum of 2 quarters · filed 2024-02-29 | $34.74M derived: sum of 3 quarters · filed 2024-02-29 | $36.74M 10-K · filed 2024-02-29 |
| 2021-09-30 | $28.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $34.13M derived: sum of 2 quarters · filed 2022-11-08 | $36.13M 10-Q · filed 2022-11-08 | $38.20M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $5.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $7.27M 10-Q · filed 2022-08-09 | $9.34M derived: sum of 3 quarters · filed 2023-03-01 | $11.40M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $2.00M 10-Q · filed 2022-05-10 | $4.07M derived: sum of 2 quarters · filed 2023-03-01 | $6.13M derived: sum of 3 quarters · filed 2023-03-01 | $8.07M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $2.07M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $4.13M derived: sum of 2 quarters · filed 2023-03-01 | $6.07M derived: sum of 3 quarters · filed 2023-03-01 | $8.40M 10-K · filed 2023-03-01 |
| 2020-09-30 | $2.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $4.00M derived: sum of 2 quarters · filed 2021-11-09 | $6.33M 10-Q · filed 2021-11-09 | $7.94M derived: sum of 4 quarters · filed 2022-03-11 |
| 2020-06-30 | $1.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $4.27M 10-Q · filed 2021-08-09 | $5.88M derived: sum of 3 quarters · filed 2022-03-11 | $7.48M derived: sum of 4 quarters · filed 2022-03-11 |
| 2020-03-31 | $2.33M 10-Q · filed 2021-05-07 | $3.94M derived: sum of 2 quarters · filed 2022-03-11 | $5.54M derived: sum of 3 quarters · filed 2022-03-11 | $7.11M derived: sum of 4 quarters · filed 2022-03-11 |
| 2019-12-31 | $1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $3.21M derived: sum of 2 quarters · filed 2022-03-11 | $4.78M derived: sum of 3 quarters · filed 2022-03-11 | $6.43M 10-K · filed 2022-03-11 |
| 2019-09-30 | $1.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $3.16M derived: sum of 2 quarters · filed 2020-11-06 | $4.82M 10-Q · filed 2020-11-06 | $6.23M derived: sum of 4 quarters · filed 2021-03-15 |
| 2019-06-30 | $1.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $3.22M 10-Q · filed 2020-08-07 | $4.63M derived: sum of 3 quarters · filed 2021-03-15 | $6.09M derived: sum of 4 quarters · filed 2021-03-15 |
| 2019-03-31 | $1.66M 10-Q · filed 2020-05-11 | $3.06M derived: sum of 2 quarters · filed 2021-03-15 | $4.53M derived: sum of 3 quarters · filed 2021-03-15 | $5.95M derived: sum of 4 quarters · filed 2021-03-15 |
| 2018-12-31 | $1.41M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $2.87M derived: sum of 2 quarters · filed 2021-03-15 | $4.29M derived: sum of 3 quarters · filed 2021-03-15 | $5.71M 10-K · filed 2021-03-15 |
| 2018-09-30 | $1.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $2.89M derived: sum of 2 quarters · filed 2019-11-08 | $4.30M 10-Q · filed 2019-11-08 | $5.63M derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-06-30 | $1.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $2.83M 10-Q · filed 2019-08-09 | $4.17M derived: sum of 3 quarters · filed 2020-03-16 | $9.93M derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-03-31 | $1.41M 10-Q · filed 2019-05-10 | $2.74M derived: sum of 2 quarters · filed 2020-03-16 | $8.51M derived: sum of 3 quarters · filed 2020-03-16 | $9.78M derived: sum of 4 quarters · filed 2020-03-16 |
| 2017-12-31 | $1.33M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $7.09M derived: sum of 2 quarters · filed 2020-03-16 | $8.37M derived: sum of 3 quarters · filed 2020-03-16 | $9.71M 10-K · filed 2020-03-16 |
| 2017-09-30 | $5.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $7.04M derived: sum of 2 quarters · filed 2018-11-09 | $8.38M 10-Q · filed 2018-11-09 | $13.06M derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-06-30 | $1.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $2.62M 10-Q · filed 2018-08-09 | $7.30M derived: sum of 3 quarters · filed 2019-03-15 | $10.86M derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-03-31 | $1.34M 10-Q · filed 2018-05-10 | $6.03M derived: sum of 2 quarters · filed 2019-03-15 | $9.58M derived: sum of 3 quarters · filed 2019-03-15 | $10.94M derived: sum of 4 quarters · filed 2019-03-15 |
| 2016-12-31 | $4.68M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $8.24M derived: sum of 2 quarters · filed 2019-03-15 | $9.60M derived: sum of 3 quarters · filed 2019-03-15 | $14.65M 10-K · filed 2019-03-15 |
| 2016-09-30 | $3.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $4.91M derived: sum of 2 quarters · filed 2017-11-09 | $9.97M 10-Q · filed 2017-11-09 | $14.99M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-06-30 | $1.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $6.41M 10-Q · filed 2017-08-09 | $11.43M derived: sum of 3 quarters · filed 2018-03-14 | $12.88M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-03-31 | $5.06M 10-Q · filed 2017-05-10 | $10.07M derived: sum of 2 quarters · filed 2018-03-14 | $11.52M derived: sum of 3 quarters · filed 2018-03-14 | $12.86M derived: sum of 4 quarters · filed 2018-03-14 |
| 2015-12-31 | $5.02M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $6.47M derived: sum of 2 quarters · filed 2018-03-14 | $7.80M derived: sum of 3 quarters · filed 2018-03-14 | $8.99M 10-K · filed 2018-03-14 |
| 2015-09-30 | $1.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $2.78M derived: sum of 2 quarters · filed 2016-11-09 | $3.97M 10-Q · filed 2016-11-09 | $5.04M derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-06-30 | $1.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $2.52M 10-Q · filed 2016-08-09 | $3.59M derived: sum of 3 quarters · filed 2017-03-15 | $4.71M derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-03-31 | $1.19M 10-Q · filed 2016-05-10 | $2.26M derived: sum of 2 quarters · filed 2017-03-15 | $3.38M derived: sum of 3 quarters · filed 2017-03-15 | $8.74M derived: sum of 4 quarters · filed 2017-03-15 |
| 2014-12-31 | $1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $2.18M derived: sum of 2 quarters · filed 2017-03-15 | $7.54M derived: sum of 3 quarters · filed 2017-03-15 | $8.22M 10-K · filed 2017-03-15 |
| 2014-09-30 | $1.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $6.48M derived: sum of 2 quarters · filed 2015-11-13 | $7.15M 10-Q · filed 2015-11-13 | $7.85M derived: sum of 4 quarters · filed 2016-03-15 |
| 2014-06-30 | $5.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $6.03M 10-Q · filed 2015-08-13 | $6.73M derived: sum of 3 quarters · filed 2016-03-15 | $7.31M derived: sum of 4 quarters · filed 2016-03-15 |
| 2014-03-31 | $673.00K 10-Q · filed 2015-05-14 | $1.37M derived: sum of 2 quarters · filed 2016-03-15 | $1.95M derived: sum of 3 quarters · filed 2016-03-15 | |
| 2013-12-31 | $701.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $1.28M derived: sum of 2 quarters · filed 2016-03-15 | $2.15M 10-K · filed 2016-03-15 | |
| 2013-09-30 | $577.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $1.45M 10-Q · filed 2014-11-13 | ||
| 2013-06-30 | $874.00K 10-Q · filed 2014-08-13 | |||
| 2012-12-31 | $874.00K 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |